Tag: #Global Trends

The stock market recently witnessed a significant sell-off of UniQure (a Dutch biotech firm), wiping out nearly $500 million in... Read more

The Committee for Medicinal Products for Human Use (CHMP) has issued landmark recommendations, paving the way for advanced medicines and... Read more

Merck & Co. has announced plans to reduce its workforce at its vaccine manufacturing facility in Durham, North Carolina. This... Read more

Data presented at the 2026 ASCO Genitourinary Cancers Symposium suggest that Merck’s Welireg is poised to redefine the treatment landscape... Read more

On February 26, 2026, Quotient Sciences, a leading CRDMO, and global biopharmaceutical company Ipsen announced the extension of their commercial... Read more

The European Health and Digital Executive Agency (HaDEA) has selected a consortium comprising SK bioscience, IDT Biologika, and Vaxxas for... Read more

Doug Ingram, who has led Sarepta Therapeutics for nearly a decade, announced his plans to retire by the end of... Read more

On February 26, 2026, Boehringer Ingelheim secured an exclusive global license for a preclinical small-molecule inhibitor program from Sitryx Therapeutics.... Read more

Novartis has unveiled plans to construct a new radioligand therapy (RLT) manufacturing facility in Denton, Texas. This project marks a... Read more